{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T18:16:44Z","timestamp":1781374604770,"version":"3.54.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,10,14]],"date-time":"2008-10-14T00:00:00Z","timestamp":1223942400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1007\/s00592-008-0069-0","type":"journal-article","created":{"date-parts":[[2008,10,13]],"date-time":"2008-10-13T16:01:42Z","timestamp":1223913702000},"page":"127-134","source":"Crossref","is-referenced-by-count":25,"title":["Association of C-reactive protein and hyperuricemia with diabetic nephropathy in Chinese type 2 diabetic patients"],"prefix":"10.1007","volume":"46","author":[{"given":"Chen-Chung","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Du-An","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-hung","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Hsiao","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,10,14]]},"reference":[{"key":"69_CR1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2337\/diacare.19.1.79","volume":"19","author":"AA Alzaid","year":"1996","unstructured":"Alzaid AA (1996) Microalbuminuria in patients with NIDDM: an overview. Diabetes Care 19:79\u201389","journal-title":"Diabetes Care"},{"key":"69_CR2","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1056\/NEJM198402093100605","volume":"310","author":"CE Mogensen","year":"1984","unstructured":"Mogensen CE (1984) Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310:356\u2013360","journal-title":"N Engl J Med"},{"key":"69_CR3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1464-5491.1984.tb01915.x","volume":"1","author":"RJ Jarrett","year":"1984","unstructured":"Jarrett RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmud U, Murrells TJ (1984) Microalbuminuria predicts mortality in non-insulin-dependent diabetics. Diabetes Med 1:17\u201319","journal-title":"Diabetes Med"},{"key":"69_CR4","doi-asserted-by":"crossref","first-page":"916","DOI":"10.2337\/diab.44.8.916","volume":"44","author":"R Klein","year":"1995","unstructured":"Klein R, Klein BE, Moss SE, Cruickshanks KJ (1995) Ten-year incidence of gross proteinuria in people with diabetes. Diabetes 44:916\u2013923","journal-title":"Diabetes"},{"key":"69_CR5","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/bmj.296.6616.156","volume":"296","author":"HH Parving","year":"1988","unstructured":"Parving HH, Hommel E, Mathiesen E, Sk\u00f8tt P, Edsberg B, Bahnsen M, Lauritzen M, Hougaard P, Lauritzen E (1988) Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. Br Med J (Clin Res Ed) 296:156\u2013160","journal-title":"Br Med J (Clin Res Ed)"},{"key":"69_CR6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2796.1990.tb00244.x","volume":"228","author":"A Schmitz","year":"1990","unstructured":"Schmitz A, Christensen T, Moller A, Mogensen CE (1990) Kidney function and cardiovascular risk factors in non-insulin- dependent diabetics (NIDDM) with microalbuminuria. J Intern Med 228:347\u2013352","journal-title":"J Intern Med"},{"key":"69_CR7","doi-asserted-by":"crossref","first-page":"144A","DOI":"10.1007\/BF00418267","volume":"34","author":"S Nielsen","year":"1991","unstructured":"Nielsen S, Schmitz A, Mogensen CE (1991) Rate of progression of nephropathy in normo- and micro-albuminuric type II diabetic patients. Diabetologia 34:144A","journal-title":"Diabetologia"},{"key":"69_CR8","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1046\/j.1365-2362.2001.00812.x","volume":"31","author":"S Bo","year":"2001","unstructured":"Bo S, Cavallo-Perin P, Gentile L, Repetti E, Pagano G (2001) Hypouricemia and hyperuricemia in type 2 diabetes: two different phenotypes. Eur J Clin Invest 31:318\u2013321","journal-title":"Eur J Clin Invest"},{"key":"69_CR9","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1523-1755.2005.00459.x","volume":"68","author":"CH Tseng","year":"2005","unstructured":"Tseng CH (2005) Correlation of uric acid and urinary albumin excretion rate in patients with type 2 diabetes mellitus in Taiwan. Kidney Int 68:796\u2013801","journal-title":"Kidney Int"},{"key":"69_CR10","first-page":"929","volume":"6","author":"M Molnar","year":"2000","unstructured":"Molnar M, Wittmann I, Nagy J (2000) Prevalence, course and risk factors of diabetic nephropathy in type-2 diabetes mellitus. Med Sci Monit 6:929\u2013936","journal-title":"Med Sci Monit"},{"key":"69_CR11","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2337\/diacare.18.6.793","volume":"18","author":"KU Lee","year":"1995","unstructured":"Lee KU, Park JY, Kim SW, Lee MH, Kim GS, Park SK, Park JS (1995) Prevalence and associated features of albuminuria in Koreans with NIDDM. Diabetes Care 18:793\u2013799","journal-title":"Diabetes Care"},{"key":"69_CR12","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.2337\/diacare.18.8.1140","volume":"18","author":"VR Collins","year":"1995","unstructured":"Collins VR, Dowse GK, Plehwe WE, Imo TT, Toelupe PM, Taylor HR, Zimmet PZ (1995) High prevalence of diabetic retinopathy and nephropathy in Polynesians of Western Samoa. Diabetes Care 18:1140\u20131149","journal-title":"Diabetes Care"},{"key":"69_CR13","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.2337\/diacare.24.10.1764","volume":"24","author":"RC Go","year":"2001","unstructured":"Go RC, Desmond R, Roseman JM, Bell DS, Vanichanan C, Acton RT (2001) Prevalence and risk factors of microalbuminuria in a cohort of African-American women with gestational diabetes. Diabetes Care 24:1764\u20131769","journal-title":"Diabetes Care"},{"key":"69_CR14","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.diabres.2006.06.024","volume":"75","author":"B Lu","year":"2007","unstructured":"Lu B, Wen J, Song XY, Dong XH, Yang YH, Zhang ZY, Zhao NQ, Ye HY, Mou B, Chen FL, Liu Y, Shen Y, Wang XC, Zhou LN, Li YM, Zhu XX, Hu RM (2007) High prevalence of albuminuria in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown. Diabetes Res Clin Pract 75:184\u2013192","journal-title":"Diabetes Res Clin Pract"},{"key":"69_CR15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/01.CIR.99.2.237","volume":"99","author":"W Koenig","year":"1999","unstructured":"Koenig W, Sund M, Frohlich M, Fischer HG, L\u00f6wel H, D\u00f6ring A, Hutchinson WL, Pepys MB (1999) C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Circulation 99:237\u2013242","journal-title":"Circulation"},{"key":"69_CR16","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","volume":"36","author":"PM Ridker","year":"1997","unstructured":"Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 36:973\u2013979","journal-title":"N Engl J Med"},{"key":"69_CR17","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1046\/j.1523-1755.2000.00331.x","volume":"58","author":"A Festa","year":"2000","unstructured":"Festa A, D\u2019Agostino R, Howard G, Mykk\u00e4nen L, Tracy RP, Haffner SM (2000) Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. Kidney Int 58:1703\u20131710","journal-title":"Kidney Int"},{"key":"69_CR18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0272-6386(03)00408-6","volume":"42","author":"JF Navarro","year":"2003","unstructured":"Navarro JF, Mora C, Maca M, Garca J (2003) Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus. Am J Kidney Dis 42:53\u201361","journal-title":"Am J Kidney Dis"},{"key":"69_CR19","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2337\/diabetes.51.4.1157","volume":"51","author":"CD Stehouwer","year":"2002","unstructured":"Stehouwer CD, Gall MA, Twisk JW, Knudsen E, Emeis JJ, Parving HH (2002) Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes 51:1157\u20131165","journal-title":"Diabetes"},{"key":"69_CR20","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1161\/01.ATV.0000013786.80104.D4","volume":"22","author":"A Jager","year":"2002","unstructured":"Jager A, van Hinsbergh VW, Kostense PJ, Emeis JJ, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD (2002) C-reactive protein and soluble vascular cell adhesion-1 are associated with elevated urinary albumin excretion but do not explain its link with cardiovascular risk. Arterioscler Thromb Vasc Biol 22:593\u2013598","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"69_CR21","first-page":"298","volume":"57","author":"CK Yeo","year":"2002","unstructured":"Yeo CK, Hapizah MN, Khalid BA, Nazaimoon WM, Khalid Y (2002) New coronary risk factors: is there a difference between diabetic patients with microalbuminuria compared to those without microalbuminuria? Med J Malaysia 57:298\u2013303","journal-title":"Med J Malaysia"},{"key":"69_CR22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.diabres.2004.02.009","volume":"66","author":"MB Gomes","year":"2004","unstructured":"Gomes MB, Nogueira VG (2004) Acute-phase proteins and microalbuminuria among patients with type 2 diabetes. Diabetes Res Clin Pract 66:31\u201339","journal-title":"Diabetes Res Clin Pract"},{"key":"69_CR23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.18773\/austprescr.2001.009","volume":"24","author":"BJ Nankivell","year":"2001","unstructured":"Nankivell BJ (2001) Creatinine clearance and the assessment of renal function. Aust Prescr 24:15\u201317","journal-title":"Aust Prescr"},{"key":"69_CR24","first-page":"107","volume-title":"Gout, hyperuricaemia, and other crystal-associated arthropathies","author":"W Mikkelsen","year":"1999","unstructured":"Mikkelsen W (1999) The epidemiology of hyperuricaemia and gout. In: Smyth C, Holers V (eds) Gout, hyperuricaemia, and other crystal-associated arthropathies. Marcel Dekker, New York, pp 107\u2013119"},{"key":"69_CR25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1291\/hypres.21.81","volume":"21","author":"H Shionoiri","year":"1998","unstructured":"Shionoiri H, Sugimoto K, Kosaka T, Kita E, Oda H, Ushikubo T, Goto T, Takasaki I, Yasuda G (1998) Long-term therapy with an ACE inhibitor, temocapril, reduces microalbuminuria in essential hypertension. Hypertens Res 21:81\u201387","journal-title":"Hypertens Res"},{"key":"69_CR26","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00228-005-0961-2","volume":"61","author":"R Fogari","year":"2005","unstructured":"Fogari R, Mugellini A, Zoppi A, Lazzari P, Destro M, Rinaldi A, Preti P (2005) Effect of successful hypertension control by manidipine or lisinopril on albuminuria and left ventricular mass in diabetic hypertensive patients with microalbuminuria. Eur J Clin Pharmacol 61:483\u2013490","journal-title":"Eur J Clin Pharmacol"},{"key":"69_CR27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.286.1.64","volume":"286","author":"MA Albert","year":"2001","unstructured":"Albert MA, Danielson E, Rifai N, Ridker PM, P R I N C E Investigators (2001) Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation\/CRP evaluation (PRINCE): a randomized trial and cohort study. J Am Med Assoc 286:64\u201370","journal-title":"J Am Med Assoc"},{"key":"69_CR28","doi-asserted-by":"crossref","first-page":"33A","DOI":"10.1016\/j.amjcard.2005.11.014","volume":"97","author":"S Mora","year":"2006","unstructured":"Mora S, Ridker PM (2006) Justification for the use of statins in primary prevention: an intervention trial evaluating rosuvastatin (JUPITER)\u2013can C-reactive protein be used to target statin therapy in primary prevention? Am J Cardiol 97:33A\u201341A","journal-title":"Am J Cardiol"},{"key":"69_CR29","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1161\/01.CIR.102.18.2165","volume":"102","author":"V Pasceri","year":"2000","unstructured":"Pasceri V, Willerson JT, Yeh ET (2000) Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102:2165\u20132168","journal-title":"Circulation"},{"key":"69_CR30","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/01.CIR.0000029802.88087.5E","volume":"106","author":"S Verma","year":"2002","unstructured":"Verma S, Wang CH, Li SH, Dumont AS, Fedak PW, Badiwala MV, Dhillon B, Weisel RD, Li RK, Mickle DA, Stewart DJ (2002) A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 106:913\u2013919","journal-title":"Circulation"},{"key":"69_CR31","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1007\/s00125-003-1194-5","volume":"46","author":"M Saraheimo","year":"2003","unstructured":"Saraheimo M, Teppo AM, Forsblom C, Fagerudd J, Groop PH (2003) Diabetic nephropathy is associated with low-grade inflammation in type 1 diabetic patients. Diabetologia 46:1402\u20131407","journal-title":"Diabetologia"},{"key":"69_CR32","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ahj.2006.02.015","volume":"152","author":"SG Lakoski","year":"2006","unstructured":"Lakoski SG, Cushman M, Criqui M, Rundek T, Blumenthal RS, D\u2019Agostino RB Jr, Herrington DM (2006) Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort. Am Heart J 152:593\u2013598","journal-title":"Am Heart J"},{"key":"69_CR33","doi-asserted-by":"crossref","first-page":"407","DOI":"10.47102\/annals-acadmedsg.V33N4p407","volume":"33","author":"AF Low","year":"2004","unstructured":"Low AF, Seow SC, Yeoh KG, Lim YT, Tan HC, Yeo TC (2004) High-sensitivity C-reactive protein is predictive of medium-term cardiac outcome in high-risk Asian patients presenting with chest pain syndrome without myocardial infarction. Ann Acad Med Singapore 33:407\u2013412","journal-title":"Ann Acad Med Singapore"},{"key":"69_CR34","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2169\/internalmedicine.43.919","volume":"43","author":"M Nakamura","year":"2004","unstructured":"Nakamura M, Onoda T, Itai K, Ohsawa M, Satou K, Sakai T, Segawa T, Sasaki J, Tonari Y, Hiramori K, Okayama A (2004) Association between serum C-reactive protein levels and microalbuminuria: a population-based cross-sectional study in northern Iwate, Japan. Intern Med 43:919\u2013925","journal-title":"Intern Med"},{"key":"69_CR35","unstructured":"No authors listed (1985). Prevalence of small vessel and large vessel disease in diabetic patients from 14 centers: The World Health Organization Multinational Study of Vascular Disease in Diabetics. Diabetes Drafting Group. Diabetologia, 28 (Suppl.): 615\u2013640"},{"key":"69_CR36","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/hy1101.092839","volume":"38","author":"M Mazzali","year":"2002","unstructured":"Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL, Lan HY, Kivlighn S, Johnson RJ (2002) Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 38:1101\u20131106","journal-title":"Hypertension"},{"key":"69_CR37","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00004872-200402000-00001","volume":"22","author":"DH Kang","year":"2004","unstructured":"Kang DH, Finch J, Nakagawa T, Karumanchi SA, Kanellis J, Granger J, Johnson RJ (2004) Uric acid, endothelial dysfunction and pre-eclampsia: searching for a pathogenetic link. J Hypertens 22:229\u2013235","journal-title":"J Hypertens"},{"key":"69_CR38","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1182\/blood.V89.2.577","volume":"89","author":"MG Netea","year":"1999","unstructured":"Netea MG, Kullberg BJ, Blok WL, Netea RT, van der Meer JW (1999) The role of hyperuricemia in the increased cytokine production after lipopolysaccharide challenge in neutropenic mice. Blood 89:577\u2013582","journal-title":"Blood"},{"key":"69_CR39","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1161\/01.HYP.0000072820.07472.3B","volume":"41","author":"J Kanellis","year":"2003","unstructured":"Kanellis J, Watanabe S, Li JH, Kang DH, Li P, Nakagawa T, Wamsley A, Sheikh-Hamad D, Lan HY, Feng L, Johnson RJ (2003) Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 41:1287\u20131293","journal-title":"Hypertension"},{"key":"69_CR40","doi-asserted-by":"crossref","unstructured":"Coutinho Tde A, Turner ST, Peyser PA, Bielak LF, Sheedy PF 2nd, Kullo IJ (2007). Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis. Am J Hypertens 20:83\u201389","DOI":"10.1016\/j.amjhyper.2006.06.015"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-008-0069-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-008-0069-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-008-0069-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T16:00:16Z","timestamp":1709308816000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-008-0069-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,14]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["69"],"URL":"https:\/\/doi.org\/10.1007\/s00592-008-0069-0","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,14]]}}}